What was claimed

An internal AMA email was sent to 847,000 doctors directing them not to recommend PEMF/frequency therapies or risk losing their license, despite acknowledging it works for tissue regeneration, pain, immune modulation, and even cancer — all to protect pharmaceutical revenue. Doctors know frequency heals but stay silent.

Our verdict

Needs Caution

This asserts a specific covert motive for a purported AMA directive without any supporting evidence and attributes regulatory and practice patterns to protecting pharmaceutical revenue. Decisions about therapies typically hinge on evidence, regulation, and safety, and there is no documented AMA policy or email stating this motive. This is a sweeping generalization implying near-universal secret knowledge and deliberate silence among doctors, which is not supported by evidence. Some clinicians use or study PEMF and related modalities for specific indications, but many remain skeptical or cautious due to mixed or limited evidence, and their positions are openly discussed in the literature and policy documents.

0 of 3 AI systems agree12 sources citedChecked Jul 20, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

The directive was issued "all to protect pharmaceutical revenue."

Incorrect90%
1 of 2 AIs agree·Claude: Can’t verify

Doctors know frequency heals but stay silent.

Misleading80%
2 of 3 AIs agree·Claude: Can’t verify

The directive (if true) was motivated by protecting pharmaceutical revenue.

Can’t verify80%
1 AI checked

An internal AMA email was sent to 847,000 doctors directing them not to recommend PEMF/frequency therapies or risk losing their license.

Can’t verify82%
3 of 6 AIs agree·Claude: Incorrect, ChatGPT: Incorrect, Perplexity: Misleading

The email acknowledged PEMF/frequency therapies work for tissue regeneration, pain, immune modulation, and even cancer.

Can’t verify84%
3 of 4 AIs agree·Claude: Misleading

Detailed Analysis

There is no evidence of any internal AMA email of this kind or of such a directive to hundreds of thousands of doctors. The response makes sweeping claims about doctors’ knowledge, licensing threats, and pharmaceutical motives that are unsupported and contradicted by available information. Some general statements about PEMF’s potential benefits are partially aligned with emerging research, but they are exaggerated and framed in a conspiratorial way.

Why this verdict

  • There is no evidence of any internal AMA email of this kind or of such a directive to hundreds of thousands of doctors.
  • The response makes sweeping claims about doctors’ knowledge, licensing threats, and pharmaceutical motives that are unsupported and contradicted by available information.
  • Some general statements about PEMF’s potential benefits are partially aligned with emerging research, but they are exaggerated and framed in a conspiratorial way.

Claims checked

The directive was issued "all to protect pharmaceutical revenue."

Incorrect90%
This asserts a specific covert motive for a purported AMA directive without any supporting evidence and attributes regulatory and practice patterns to protecting pharmaceutical revenue. Decisions about therapies typically hinge on evidence, regulation, and safety, and there is no documented AMA policy or email stating this motive.[7] [8] [12]

This claim may mislead readers without added context.

Doctors know frequency heals but stay silent.

Misleading85%
This is a sweeping generalization implying near-universal secret knowledge and deliberate silence among doctors, which is not supported by evidence. Some clinicians use or study PEMF and related modalities for specific indications, but many remain skeptical or cautious due to mixed or limited evidence, and their positions are openly discussed in the literature and policy documents.[7] [8] [6]

This claim may mislead readers without added context.

PEMF/frequency therapies work for cancer.

Misleading86%
Early preclinical and small clinical studies explore PEMF and related modalities in certain cancers, but evidence is preliminary and not sufficient to claim that PEMF "works" as a general cancer treatment.[4] [12] FDA approvals related to cancer involve very specific indications (e.g., certain brain tumors) and do not generalize to all cancers, so the claim overstates current evidence.[12]

This claim may mislead readers without added context.

What other AI think

The claim relies entirely on an unverifiable conspiracy narrative from fringe sources with no corroboration in credible medical, regulatory, or news sources. The core assertion—an AMA email threatening doctors—appears nowhere in official records or mainstream documentation. While PEMF has some legitimate FDA approvals for specific uses, the broader claims about efficacy and suppression contradict actual scientific evidence showing inconclusive results.

Why this verdict

  • The claim relies entirely on an unverifiable conspiracy narrative from fringe sources with no corroboration in credible medical, regulatory, or news sources.
  • The core assertion—an AMA email threatening doctors—appears nowhere in official records or mainstream documentation.
  • While PEMF has some legitimate FDA approvals for specific uses, the broader claims about efficacy and suppression contradict actual scientific evidence showing inconclusive results.

Claims checked

An internal AMA email was sent to 847,000 doctors directing them not to recommend PEMF/frequency therapies or risk losing their license

Incorrect95%
This email appears only in fringe conspiracy websites from July 2026 with no corroboration in official AMA records, regulatory databases, mainstream news, or credible medical sources. The claim is unverifiable and contradicted by the absence of any documentation in legitimate channels.

This claim may mislead readers without added context.

The AMA acknowledged PEMF works for tissue regeneration, pain, immune modulation, and cancer

Misleading90%
While PEMF has FDA approval for specific applications like bone healing, the scientific literature shows evidence is inconclusive for most claimed uses. Cancer efficacy in particular lacks strong clinical evidence. The claim overstates the consensus.

This claim may mislead readers without added context.

The suppression is to protect pharmaceutical revenue

Can’t verify60%
This is speculative motivation attribution with no supporting evidence. The actual regulatory caution around PEMF appears based on insufficient clinical evidence rather than conspiracy.
I found no credible evidence that the AMA sent an internal email to 847,000 doctors with those instructions. The numeric and attribution details conflict with verifiable facts about AMA membership and public communications. The broad medical claims about PEMF curing cancer and the stated motive (protecting pharmaceutical revenue) are unsupported by reliable sources.

Why this verdict

  • I found no credible evidence that the AMA sent an internal email to 847,000 doctors with those instructions.
  • The numeric and attribution details conflict with verifiable facts about AMA membership and public communications.
  • The broad medical claims about PEMF curing cancer and the stated motive (protecting pharmaceutical revenue) are unsupported by reliable sources.

Claims checked

An internal AMA email was sent to 847,000 doctors directing them not to recommend PEMF/frequency therapies or risk losing their license.

Incorrect95%
There is no public record or reporting of such an AMA communication, and the AMA does not have 847,000 physician members to whom it would send an internal notice. Public AMA communications and policies on physician conduct do not match this claim.

This claim may mislead readers without added context.

Doctors know frequency heals but stay silent.

Misleading75%
This is a broad, generalized assertion about all or most doctors that lacks evidence; clinician views on PEMF vary and silence can have many causes, so the claim is misleading as stated.

This claim may mislead readers without added context.

The directive (if true) was motivated by protecting pharmaceutical revenue.

Can’t verify80%
Attributing motive (protecting pharmaceutical revenue) is speculative and unsupported by verifiable evidence; no reliable sources link the AMA to such a financial motive in this context.

Share this result